These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 9115956)

  • 21. Contributions of neuroendocrine and local autocrine-paracrine mechanisms to the pathophysiology and pharmacology of congestive heart failure.
    Dzau VJ
    Am J Cardiol; 1988 Sep; 62(8):76E-81E. PubMed ID: 2901216
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Responses of vasoactive hormones in congestive cardiac failure.
    Johnston CI; Arnolda LF; Tsunoda K; Phillips PA; Hodsman GP
    Can J Physiol Pharmacol; 1987 Aug; 65(8):1706-11. PubMed ID: 2961425
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neurohormonal activation and the response to converting enzyme inhibitors in congestive heart failure.
    Kubo SH
    Circulation; 1990 Feb; 81(2 Suppl):III107-14. PubMed ID: 2137052
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Heart failure due to ischemia--the adaptive mechanisms].
    Mitu M; Mitu F
    Rev Med Chir Soc Med Nat Iasi; 1999; 103(1-2):16-23. PubMed ID: 10756879
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of neuroendocrine mechanisms in the pathogenesis of heart failure.
    Riegger AJ
    Basic Res Cardiol; 1991; 86 Suppl 3():125-31. PubMed ID: 1838244
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hormonal profile in mild heart failure.
    Volpe M; Tritto C; Condorelli M
    Acta Cardiol; 1993; 48(5):483-94. PubMed ID: 8284989
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pathophysiology and clinical spectrum of acute congestive heart failure.
    Shah M; Ali V; Lamba S; Abraham WT
    Rev Cardiovasc Med; 2001; 2 Suppl 2():S2-6. PubMed ID: 12439355
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Heart failure: role of cardiovascular reflexes.
    Shepherd JT
    Cardioscience; 1990 Mar; 1(1):7-12. PubMed ID: 2151712
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Pathophysiology of left heart failure with reference to hemodynamic and neurohumoral changes].
    Schmieder RE
    Acta Med Austriaca; 1992; 19(3):77-82. PubMed ID: 1357906
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Neurohormonal activation in congestive heart failure: does it normalize after heart transplantation?].
    Pérez-Villa F; Roig E; Ferrer E; Cuppoletti A; Llancaqueo M; Jiménez W; Sanz G
    Rev Esp Cardiol; 2004 Aug; 57(8):725-31. PubMed ID: 15282060
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Atrial natriuretic peptide in congestive heart failure.
    Fyhrquist F; Tikkanen I
    Am J Cardiol; 1988 Jul; 62(2):20A-24A. PubMed ID: 2968757
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cardiorenal and neurohumoral effects of endogenous atrial natriuretic peptide in dogs with severe congestive heart failure using a specific antagonist for guanylate cyclase-coupled receptors.
    Wada A; Tsutamoto T; Matsuda Y; Kinoshita M
    Circulation; 1994 May; 89(5):2232-40. PubMed ID: 7910118
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neuroendocrine response to standing and mild exercise in patients with untreated severe congestive heart failure and chronic constrictive pericarditis.
    Ferrari R; Anand IS; Ceconi C; De Giuli F; Poole-Wilson PA; Harris P
    Heart; 1996 Jul; 76(1):50-5. PubMed ID: 8774327
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Flosequinan, a new vasodilator: systemic and coronary hemodynamics and neuroendocrine effects in congestive heart failure.
    Cavero PG; De Marco T; Kwasman M; Lau D; Liu M; Chatterjee K
    J Am Coll Cardiol; 1992 Dec; 20(7):1542-8. PubMed ID: 1452928
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neuroendocrine activation after myocardial infarction: causes and consequences.
    Cleland JG; Cowburn PJ; Morgan K
    Heart; 1996 Nov; 76(3 Suppl 3):53-9. PubMed ID: 8977365
    [No Abstract]   [Full Text] [Related]  

  • 36. Pathophysiology of fluid retention in heart failure.
    Chaney E; Shaw A
    Contrib Nephrol; 2010; 164():46-53. PubMed ID: 20427993
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neuroendocrine activity in congestive heart failure.
    Francis GS
    Am J Cardiol; 1990 Oct; 66(11):33D-38D; discussion 38D-39D. PubMed ID: 2220603
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Neuroendocrine activation in heart failure I. Pathophysiology and pharmacological intervention].
    Kjaer A
    Ugeskr Laeger; 2000 Oct; 162(44):5905-9. PubMed ID: 11094549
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pathophysiologic role of the renin-angiotensin-aldosterone and sympathetic nervous systems in heart failure.
    Adams KF
    Am J Health Syst Pharm; 2004 May; 61 Suppl 2():S4-13. PubMed ID: 15160833
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The neuroendocrine and sympathetic nervous system in congestive heart failure.
    Ferrari R; Ceconi C; Curello S; Visioli O
    Eur Heart J; 1998 Jun; 19 Suppl F():F45-51. PubMed ID: 9651735
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.